MedTrace Logo

A Multinational Trial To Evaluate The Parachute Implant System

NCT01286116 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2017-06-23

No results posted yet for this study

Summary

The primary objective is to assess the safety of the CardioKinetix Parachute Implant and Delivery System in the partitioning of the left ventricle in patients with heart failure due to ischemic heart disease.

Conditions

Interventions

DEVICE

Parachute Implant

Mechanical ventricular partitioning

Sponsors & Collaborators

  • CardioKinetix, Inc

    lead INDUSTRY

Principal Investigators

  • Martyn Thomas, MD · St. Thomas' Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-01-31
Completion
2017-06-30

Countries

  • France
  • Germany
  • Latvia
  • Netherlands
  • Portugal
  • Serbia
  • Slovenia
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01286116 on ClinicalTrials.gov